QRVO · Qorvo, Inc.

Current Thesis

QRVO stopped trading as a standalone narrative on 2025-10-27, when Skyworks (SWKS) agreed to acquire it for $32.50 cash + 0.960 SWKS shares per QRVO share. At SWKS $73.57 (2026-06-05) the deal pencils to ~$103.13 of value; QRVO closed $98.28 the same day, a ~4.9% gross spread. The "52-week high" prints of late May were mechanical QRVO tracks SWKS up and down. That linkage was on display 2026-06-05: SWKS fell −7.96% and dragged QRVO −5.47% in one session. Both shareholder votes already cleared (2026-02-11), so the deal is no longer a vote story it is a single-gate regulatory clock (China SAMR) wrapped in a leveraged SWKS proxy. Upside is capped at deal value; downside is a binary deal-break gap. This sits outside a momentum framework stand aside on the equity itself.

Bull Case

• the SWKS stock-issuance proposal passed with 120,980,973 for vs 289,580 against (>99%). The remaining path is regulatory, not a proxy fight.
• Regulatory checkpoints advancing. Taiwan's TFTC approved the merger 2026-05-13. China SAMR has entered Phase II with "constructive dialogue," and management is "increasingly hopeful" of a late-2026 close versus formal guidance of early calendar 2027 (Form 425, May 2026).
• Deal mechanics in motion. Skyworks launched debt exchange offers in May 2026 up to $850M new 2029 notes + $700M new 2031 notes for QRVO noteholders and SWKS jumped ~12% as the deal moved into the debt-swap phase.
• Synergy/scale. $500M+ annual cost-synergy target; combined entity ~$22B equity value, ~$10.1B headline deal value.
• Standalone backstop firm. Q4 FY26 (reported 2026-05-05): Adj EPS $1.69 beat $1.21, revenue $808.3M beat $800.6M; FY27 guide EPS $7.00 vs $6.60 consensus limiting standalone downside if timing slips.

Bear Case

• Upside is capped. Maximum value ≈ $32.50 + 0.960×SWKS. To get QRVO to the Craig-Hallum $120 target (raised May 2026), SWKS must reach ~$91 so this is a long-SWKS bet with worse convexity and a delisting at the end.
• Binary downside. An FTC suit, a China SAMR rejection, or a SWKS walk gaps QRVO toward standalone ~$75–85 (52-week low $74.92) versus $98.28 a −20% to −30% air pocket.
• It eats SWKS volatility both ways. The 2026-06-05 session showed the mechanism: a SWKS −7.96% day cost QRVO holders −5.47%, with no QRVO-specific news.
• Sell-side fundamentals sit below the quote. Consensus median PT sits near $85, ~13% under the $98.28 close only the deal supports the price.
• China SAMR is the swing risk. Phase II can run many months inside a tense US-China semiconductor backdrop, with no scheduled decision date.

Setup & Price Structure

• 2026-06-05: QRVO $98.28 (−5.47%); SWKS $73.57 (−7.96%). 52-week range $74.92–$109.49, with the high printed in late May on the SWKS run.
• Value decomposition: $32.50 cash (~33% of value) + 0.960×SWKS ≈ $70.63 (~72%). QRVO is a leveraged SWKS proxy with a cash floor, governed by the exchange ratio rather than its own tape.
• Gross spread: ~$4.85 (~4.9%) to the ~$103.13 deal value at current SWKS, roughly mid-single-digit annualized to a late-2026/early-2027 close.
• Standalone moving-average and RSI reads are not decision-grade here price is set by SWKS plus completion odds, not by an accelerating QRVO story. The "above all MAs, strong trend" optics are the deal re-rating since 2025-10-27, not momentum to extrapolate.

Catalyst Calendar (next 30 days)

• No hard QRVO-specific catalyst in the 2026-06-07 → 2026-07-07 window. Shareholder approval is already in hand (2026-02-11).
• China SAMR Phase II open-ended, no published decision date; any clearance/extension/rejection headline moves the spread directly.
• SWKS daily tape is the de facto QRVO catalyst (~72% of value) watch the SWKS chart, not QRVO's.
• SWKS fiscal Q3 FY26 earnings ~early August 2026 (just outside the window) the next scheduled print that re-rates the SWKS leg and, by construction, QRVO.
• Debt exchange-offer settlement windows (tied to deal close) mechanical plumbing, not a QRVO price event.

What Would Change Our Mind

• A deal-break headline (SAMR rejection, FTC suit, SWKS walking) that re-rates QRVO into a standalone RF-semis name worth a fresh, clean look, but only after the ~−20% gap to ~$78 standalone value resolves and a new base forms.
• SAMR clearance or a definitive close date collapses the ~5% spread and converts QRVO into SWKS shares; the arb is over and there is nothing left to trade on the ticker.
• A SWKS-specific re-acceleration that makes the underlying attractive on its own in which case the cleaner expression is SWKS directly, not a capped proxy carrying deal-break tail risk.

Correlation Notes

• ~0.95+ to SWKS by construction (0.960 exchange ratio): QRVO behaves as a SWKS tracking stock plus a $32.50 cash component. The 2026-06-05 −5.47%/−7.96% pairing is the cleanest read of that beta.
• Semis index beta (SOX/SMH) runs through SWKS only; the spread component itself is low-beta to the tape.
• RF/analog peers (SWKS, AVGO) share content-cycle exposure, but QRVO's idiosyncratic driver is regulatory (China SAMR), decoupled from the RF-content cycle.
• US-China semiconductor policy is the tail-risk channel SAMR Phase II is the single chokepoint that determines whether the ~5% spread closes up or the equity gaps down.

Bottom Line

The instrument prices a regulatory clock, not a narrative. With votes cleared and Taiwan approved, the residual question is China SAMR timing a binary the chart cannot front-run. Mid-single-digit capped upside against a −20%+ break gap is not the asymmetry this playbook hunts; the equity is a pass until a deal-break headline hands back a standalone name to analyze fresh.